Drug Topics September 19, 2024
Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.
It is “highly likely” that pharmacy benefit management (PBM) legislation will cross the legislative finish line this year, according to Patrick Cooney, president of The Federal Group, a Washington, DC-based lobbying firm. Cooney was interviewed during the 2024 Pharmacy Benefit Management Institute Annual National Conference by Drug Topics’ sister publication, Managed Healthcare Executive, where he discussed the role of the Federal Trade Commission (FTC) interim report in galvanizing legislators, as well as his predictions on what provisions the potential PBM legislation might contain.
What are the chances that Congress will pass PBM legislation this year?
Patrick Cooney: I think the prospects are high. After...
Today's Sponsors
Today's Sponsor